dangers of compound semaglutide FDA is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger enforcement to protect patients from unverified Patients report alarming side effects

They may reduce over time with smaller meals, slower eating, and gradual dose escalation as advised by your doctor

Committee Launches Investigation of CMS and Five Nursing Home Chains June 17, 2020 A June 11 briefing by the Select Committee on COVID identified nursing homes longstanding problems in staffing levels and infection control, as well as the failure of the federal government to take a strong leadership position in confronting the coronavirus pandemic

Urine samples must always be obtained and maintained under hygienic conditions

By slowing down how quickly food leaves the stomach, GLP-1 reduces the amount of glucose entering the bloodstream at once

While this is a single case report and not necessarily generalizable, it underscores why thyroid monitoring during GLP-1 therapy is not optional, it is essential